Cargando…

Screening of potential molecular targets for colorectal cancer therapy

Colorectal cancer is a leading cause of cancer death worldwide. To identify molecular targets for colorectal cancer therapy, we tested small interfering RNAs (siRNAs) against 97 genes whose expression was elevated in human colorectal cancer tissues for the ability to promote apoptosis of human color...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Kimi, Takemasa, Ichiro, Matoba, Ryo, Yamamoto, Yusuke, Takeshita, Fumitaka, Mori, Masaki, Monden, Morito, Matsubara, Kenichi, Ochiya, Takahiro
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840570/
https://www.ncbi.nlm.nih.gov/pubmed/20360909
_version_ 1782178996826406912
author Honma, Kimi
Takemasa, Ichiro
Matoba, Ryo
Yamamoto, Yusuke
Takeshita, Fumitaka
Mori, Masaki
Monden, Morito
Matsubara, Kenichi
Ochiya, Takahiro
author_facet Honma, Kimi
Takemasa, Ichiro
Matoba, Ryo
Yamamoto, Yusuke
Takeshita, Fumitaka
Mori, Masaki
Monden, Morito
Matsubara, Kenichi
Ochiya, Takahiro
author_sort Honma, Kimi
collection PubMed
description Colorectal cancer is a leading cause of cancer death worldwide. To identify molecular targets for colorectal cancer therapy, we tested small interfering RNAs (siRNAs) against 97 genes whose expression was elevated in human colorectal cancer tissues for the ability to promote apoptosis of human colorectal cancer cells (HT-29 cells). The results indicate that the downregulation of PSMA7 (proteasome subunit, α-type, 7) and RAN (ras-related nuclear protein) most efficiently induced apoptosis of HT-29 cells. PSMA7 and RAN were highly expressed in colorectal cancer cell lines compared with normal colon tissues. Furthermore, PSMA7 and RAN were overexpressed in not only colon tumor tissues but also the other tumor tissues. Moreover, in vivo delivery of PSMA7 siRNA and RAN siRNA markedly induced apoptosis in HT-29 xenograft tumors in mice. Thus, silencing of PSMA7 and RAN induces cancer cells to undergo apoptosis, and PSMA7 and RAN might be promising new molecular targets for drug and RNA interference-based therapeutics against colorectal cancer.
format Text
id pubmed-2840570
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-28405702010-04-01 Screening of potential molecular targets for colorectal cancer therapy Honma, Kimi Takemasa, Ichiro Matoba, Ryo Yamamoto, Yusuke Takeshita, Fumitaka Mori, Masaki Monden, Morito Matsubara, Kenichi Ochiya, Takahiro Int J Gen Med Original Research Colorectal cancer is a leading cause of cancer death worldwide. To identify molecular targets for colorectal cancer therapy, we tested small interfering RNAs (siRNAs) against 97 genes whose expression was elevated in human colorectal cancer tissues for the ability to promote apoptosis of human colorectal cancer cells (HT-29 cells). The results indicate that the downregulation of PSMA7 (proteasome subunit, α-type, 7) and RAN (ras-related nuclear protein) most efficiently induced apoptosis of HT-29 cells. PSMA7 and RAN were highly expressed in colorectal cancer cell lines compared with normal colon tissues. Furthermore, PSMA7 and RAN were overexpressed in not only colon tumor tissues but also the other tumor tissues. Moreover, in vivo delivery of PSMA7 siRNA and RAN siRNA markedly induced apoptosis in HT-29 xenograft tumors in mice. Thus, silencing of PSMA7 and RAN induces cancer cells to undergo apoptosis, and PSMA7 and RAN might be promising new molecular targets for drug and RNA interference-based therapeutics against colorectal cancer. Dove Medical Press 2009-12-29 /pmc/articles/PMC2840570/ /pubmed/20360909 Text en © 2009 Honma et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Honma, Kimi
Takemasa, Ichiro
Matoba, Ryo
Yamamoto, Yusuke
Takeshita, Fumitaka
Mori, Masaki
Monden, Morito
Matsubara, Kenichi
Ochiya, Takahiro
Screening of potential molecular targets for colorectal cancer therapy
title Screening of potential molecular targets for colorectal cancer therapy
title_full Screening of potential molecular targets for colorectal cancer therapy
title_fullStr Screening of potential molecular targets for colorectal cancer therapy
title_full_unstemmed Screening of potential molecular targets for colorectal cancer therapy
title_short Screening of potential molecular targets for colorectal cancer therapy
title_sort screening of potential molecular targets for colorectal cancer therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840570/
https://www.ncbi.nlm.nih.gov/pubmed/20360909
work_keys_str_mv AT honmakimi screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT takemasaichiro screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT matobaryo screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT yamamotoyusuke screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT takeshitafumitaka screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT morimasaki screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT mondenmorito screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT matsubarakenichi screeningofpotentialmoleculartargetsforcolorectalcancertherapy
AT ochiyatakahiro screeningofpotentialmoleculartargetsforcolorectalcancertherapy